Next Article in Journal
Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
Next Article in Special Issue
Lysine Methyltransferase 9 (KMT9) Is an Actionable Target in Muscle-Invasive Bladder Cancer
Previous Article in Journal
Comparative Effectiveness of First-Line Selpercatinib versus Standard Therapies in Patients with RET-Activated Cancers: An Exploratory Interpatient Analysis of LIBRETTO-001
Previous Article in Special Issue
Methylenetetrahydrofolate Reductase C677T (rs1801133) Polymorphism Is Associated with Bladder Cancer in Asian Population: Epigenetic Meta-Analysis as Precision Medicine Approach
 
 
Article

Article Versions Notes

Cancers 2024, 16(1), 139; https://doi.org/10.3390/cancers16010139
Action Date Notes Link
article xml file uploaded 27 December 2023 11:00 CET Original file -
article xml uploaded. 27 December 2023 11:00 CET Update -
article pdf uploaded. 27 December 2023 11:00 CET Version of Record https://www.mdpi.com/2072-6694/16/1/139/pdf-vor
article supplementary file uploaded. 27 December 2023 11:00 CET - https://www.mdpi.com/2072-6694/16/1/139#supplementary
article html file updated 27 December 2023 11:02 CET Original file -
article xml file uploaded 28 December 2023 03:19 CET Update -
article xml uploaded. 28 December 2023 03:19 CET Update https://www.mdpi.com/2072-6694/16/1/139/xml
article pdf uploaded. 28 December 2023 03:19 CET Updated version of record https://www.mdpi.com/2072-6694/16/1/139/pdf
article html file updated 28 December 2023 03:22 CET Update https://www.mdpi.com/2072-6694/16/1/139/html
Back to TopTop